Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Xingyue Biotechnology
Hangzhou (Future Sci-Tech City), Zhejiang Sheng/Zhejiang Province, Chinaxingyuebio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhejiang Xingyue Biotechnology has pioneered China’s first bioresorbable silk fibroin medical devices such as hernia repair patches and wound dressings. These products are marketed and used clinically for their biocompatibility and wound healing properties[2]. The company also sponsors clinical trials of autologous adipose-derived mesenchymal stem cells for tendon diseases; at least one trial reached Phase 2[1][5].
- Therapeutic areas
- GastroenterologyDermatologyRheumatology
- Modalities
- Cell therapyBiomaterial-based device
- Industry
- Biotech
Beyond the preview
Go deeper on Zhejiang Xingyue Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Xingyue Biotechnology.